United-Guardian (NASDAQ:UG) Stock Breaks Above 200 Day Moving Average – What’s Next?

United-Guardian, Inc. (NASDAQ:UG) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $6.95 and traded as high as $7.07. United-Guardian shares last traded at $7.07, with a volume of 15,715 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of United-Guardian in a report on Monday, October 19th. One analyst has rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of “Hold”.

United-Guardian Stock Performance

The company has a 50 day moving average of $7.05 and a 200 day moving average of $6.95. The firm has a market cap of $32.45 million, a P/E ratio of 13.09 and a beta of 0.95.

United-Guardian (NASDAQ:UG) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $3.11 million for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%.

Institutional Investors Weigh In On United-Guardian

Several institutional investors and hedge funds have recently modified their holdings of the business. United Capital Financial Advisors LLC acquired a new stake in shares of United-Guardian in the 2nd quarter valued at $143,000. BlackRock Inc. acquired a new position in United-Guardian during the second quarter worth $105,000. Finally, Gamco Investors INC. ET AL lifted its position in shares of United-Guardian by 1.2% in the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after buying an additional 1,888 shares during the last quarter. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.